Home › Alzheimer's Disease › Minnesota › Rochester
Alzheimer's Disease clinical trials in Rochester, MN
6 studies for Alzheimer's Disease are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Mayo Clinic in Rochester, Minnesota, Rochester
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Mayo Clinic - Rochester, Rochester
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
Recruiting
- Mayo Clinic, Rochester
Late Onset Alzheimer's Disease
RecruitingObservational studyHealthy volunteers welcome
- Mayo Clinic, Rochester
MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics
RecruitingHealthy volunteers welcome
- Mayo Clinic, Rochester
PROMIS and Mobility Evaluation in Sarcoma Patients
RecruitingObservational study
- Mayo Clinic, Rochester
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- Philadelphia, PA15 studies
- Phoenix, AZ15 studies
- The Villages, FL15 studies
- Los Angeles, CA14 studies
- Indianapolis, IN14 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Colorectal Cancer29 studies
- Ovarian Cancer29 studies
- Multiple Myeloma24 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Pancreatic Cancer22 studies
- Lung Cancer20 studies
- Endometrial Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.